These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 8237425)

  • 1. Renal effects of urodilatin and atrial natriuretic peptide in volume expanded conscious dogs.
    Bestle MH; Bie P
    Acta Physiol Scand; 1993 Sep; 149(1):77-83. PubMed ID: 8237425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of renal actions of urodilatin and atrial natriuretic peptide.
    Hildebrandt DA; Mizelle HL; Brands MW; Hall JE
    Am J Physiol; 1992 Mar; 262(3 Pt 2):R395-9. PubMed ID: 1313650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and action of urodilatin infusion in healthy volunteers.
    Carstens J; Jensen KT; Pedersen EB
    Clin Pharmacol Ther; 1998 Jul; 64(1):73-86. PubMed ID: 9695722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuresis in conscious dogs caused by increased carotid [Na+] during angiotensin II and aldosterone blockade.
    Emmeluth C; Drummer C; Gerzer R; Bie P
    Acta Physiol Scand; 1994 Jul; 151(3):403-11. PubMed ID: 7976412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal effects of urodilatin in healthy subjects are independent of blockade of the cyclooxygenase and angiotensin II receptor.
    Carstens J; Pedersen EB
    Scand J Clin Lab Invest; 2008; 68(1):2-10. PubMed ID: 17852806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renal paracrine peptide system--possible urologic implications of urodilatin.
    Meyer M; Stief CG; Becker AJ; Truss MC; Taher A; Jonas U; Forssmann WG
    World J Urol; 1996; 14(6):375-9. PubMed ID: 8986039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the renal effects of urodilatin and atrial natriuretic factor: effect of changes in sodium status.
    Yates NA; McDougall JG
    Exp Nephrol; 1994; 2(5):281-5. PubMed ID: 7812733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal and systemic effects of urodilatin in rats with high-output heart failure.
    Abassi ZA; Powell JR; Golomb E; Keiser HR
    Am J Physiol; 1992 Apr; 262(4 Pt 2):F615-21. PubMed ID: 1533100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
    Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N
    Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular, endocrine, and renal effects of urodilatin in normal humans.
    Bestle MH; Olsen NV; Christensen P; Jensen BV; Bie P
    Am J Physiol; 1999 Mar; 276(3):R684-95. PubMed ID: 10070128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide attenuates pressor but enhances natriuretic responses to angiotensin II in pregnant conscious goats.
    Olsson K; Hossaini-Hilali J; Eriksson L
    Acta Physiol Scand; 1992 Aug; 145(4):385-94. PubMed ID: 1388314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of synthetic human atrial natriuretic peptide (hANP) in conscious dogs.
    Johannessen AC; Schütten HJ; Torp-Pedersen C; Warberg J; Bie P
    Acta Physiol Scand; 1986 Aug; 127(4):449-54. PubMed ID: 2944353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentration and renal effect of human atrial natriuretic peptide in nephrotic syndrome.
    Hisanaga S; Yamamoto Y; Kida O; Kato J; Fujimoto S; Tanaka K
    Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):661-9. PubMed ID: 2529385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that urodilatin, rather than ANP, regulates renal sodium excretion.
    Goetz K; Drummer C; Zhu JL; Leadley R; Fiedler F; Gerzer R
    J Am Soc Nephrol; 1990 Dec; 1(6):867-74. PubMed ID: 1966524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial natriuresis in humans: further evidence that urodilatin, not ANP, modulates sodium excretion.
    Drummer C; Franck W; Heer M; Forssmann WG; Gerzer R; Goetz K
    Am J Physiol; 1996 Feb; 270(2 Pt 2):F301-10. PubMed ID: 8779891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
    Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
    Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of continuous urodilatin infusion: a dose-finding study.
    Dorner GT; Selenko N; Kral T; Schmetterer L; Eichler HG; Wolzt M
    Clin Pharmacol Ther; 1998 Sep; 64(3):322-30. PubMed ID: 9757156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
    Lee RW; Raya TE; Michael U; Foster S; Meeks T; Goldman S
    J Pharmacol Exp Ther; 1992 Jan; 260(1):349-54. PubMed ID: 1346164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide counteracts angiotensin-II-induced impairment of renal function.
    Schafferhans K; Heidbreder E; Hummel S; Heidland A
    Z Kardiol; 1988; 77 Suppl 2():78-84. PubMed ID: 2970179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal effects of atrial natriuretic peptide infusion in young and adult rats.
    Chevalier RL; Gomez RA; Carey RM; Peach MJ; Linden JM
    Pediatr Res; 1988 Sep; 24(3):333-7. PubMed ID: 2850523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.